We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
MEDI.OL

Price
253.00
Stock movement down
-8.00 (-3.07%)
Company name
Medistim ASA
Exchange
(OL
,
Currency
NOK
)
Sector
Healthcare >
Medical Devices
Markedsverdi
4.62B
Ent verdi
4.68B
Pris/omsetning
7.29
Pris/bok
12.05
Utbytte avkastning
-
Utbytte vekst
-
Vekst år
-
FCF-utbetaling
-
Etterfølgende P/E
35.25
Fremtidig P/E
27.68
PEG
-
EPS-vekst
7.99%
1 års avkastning
65.36%
3 års avkastning
-
5 års avkastning
-
10 års avkastning
-
Sist oppdatert: 2025-12-12

UTBYTTE

MEDI.OL betaler ikke utbytte

VERDSETTELSE

Verdsettelsesforhold

Loading...
Verdsettelsesforhold-data
Etterfølgende P/E35.25
Pris til OCF16.68
Pris til FCF20.11
Pris til EBITDA30.60
EV i forhold til EBITDA30.96

Verdsettelse (Salg/Bokført verdi)

Loading...
Verdsettelse (Salg/Bokført verdi) data
Pris til omsetning7.29
Pris til bok12.05
EV i forhold til salg7.37

ØKONOMI

Per aksje

Loading...
Per aksje-data
Gjeldende aksje antall18.27M
EPS (TTM)-
FCF per aksje (TTM)-

Resultatregnskap

Loading...
Resultatregnskap-data
Inntekter (TTM)-
Bruttofortjeneste (TTM)-
Driftsinntekter (TTM)-
Netto inntekt (TTM)-
EPS (TTM)-
EPS (1 år fremover)9.14

Marginer

Loading...
Marginer-data
Bruttomargin (TTM)-
Driftsmargin (TTM)-
Fortjenestemargin (TTM)-

Balanse

Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Balanse-data
Kontanter96.35M
Netto fordringer94.12M
Samlede omløpsmidler388.07M
Goodwill14.13M
Immaterielle eiendeler62.45M
Eiendom, anlegg og utstyr0.00
Sum eiendeler535.04M
Leverandørgjeld0.00
Kortsiktig/nåværende langsiktig gjeld0.00
Sum kortsiktig gjeld123.75M
Sum gjeld151.23M
Aksjonærenes egenkapital383.81M
Netto varige driftsmidler0.00

Kontantstrøm

Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Kontantstrøm-data
Kontantstrøm fra drift (TTM)-
Kapitalutgifter (TTM)-
Fri kontantstrøm (TTM)-
Utbetalt utbytte (TTM)-

Finansielle inntekter

Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Finansielle inntekter-data
Egenkapitalavkastning-
Avkastning på eiendeler-
Avkastning på investert kapital-
Kontantavkastning på investert kapital-

AKSJEINFORMASJON

Aksjediagram

Loading...
Aksjekurs-data
Åpning262.00
Daglig høy262.00
Daglig lav253.00
Daglig volum20K
Tidenes høyeste399.00
1 år analytikerestimat315.00
Beta1.19
EPS (TTM)-
Utbytte per aksje0.00
Ex-div dato9 May 2025
Neste dato for resultatpresentasjon27 Feb 2026

Nedsidepotensial

Loading...
Nedsidepotensial-data
MEDI.OLS&P500
Nåværende prisfall fra toppnotering-36.59%-1.08%
Høyeste prisfall-66.92%-19.00%
Dato for høyeste fall19 Nov 20248 Apr 2025
Gj.snittlig fall fra topp-50.46%-2.64%
Gj.snittlig tid til ny topp-6 days
Maks tid til ny topp297 days89 days
SELSKAPSOPPLYSNINGER
MEDI.OL (Medistim ASA) company logo
Markedsverdi
4.62B
Markedsverdi kategori
Mid-cap
Beskrivelse
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which are designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.
Ansatte
154
Investorrelasjoner
-
SEC-innsendelser
Adm. direktør
Land
Norway
By
Aksjetype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRESENTASJONER
ArrangementerPresentasjoner
Loading...
FORSTÅ VIRKSOMHETEN
Loading...
NYHETER OM SELSKAPET
Alle nyheterPressemeldinger
As the European market grapples with concerns over inflated AI stock valuations and shifting interest rate expectations, the pan-European STOXX Europe 600 Index recently saw a decline of 2.21%, reflec...
24. november 2025
Medistim ASA (FRA:MD1) reports its best third quarter ever with significant growth in the Americas and Asia Pacific, despite challenges in the EMEA region.
26. oktober 2025
Medistim (OB:MEDI) posted headline numbers that reinforce its growth trajectory, with revenue forecast to climb 7.5% per year, handily outpacing the wider Norwegian market’s expected 2.3% growth rate....
25. oktober 2025
As European markets continue to rally, reaching record levels on the back of strong technology stocks and expectations for lower U.S. borrowing costs, investors are increasingly optimistic about small...
7. oktober 2025
Medistim ASA (FRA:MD1) reports a robust 16.7% revenue growth in Q2 2025, driven by significant gains in the Americas and strategic product advancements.
21. august 2025
In recent weeks, European markets have seen a positive uptick, with the pan-European STOXX Europe 600 Index rising by 1.18% amid easing trade tensions and optimism surrounding potential U.S. interest ...
20. august 2025
The European market has recently seen mixed returns across major indices, with the pan-European STOXX Europe 600 Index remaining relatively flat and individual country indices showing varied performan...
9. juli 2025
As the European market experiences a positive shift, with the pan-European STOXX Europe 600 Index rising by 0.90% and major stock indexes across Germany, Italy, France, and the UK posting gains, inves...
10. juni 2025
Medistim ASA (FRA:MD1) reports a 35.7% revenue increase, driven by strong product sales and significant market expansion in Asia Pacific.
12. mai 2025
As the pan-European STOXX Europe 600 Index continues its upward trajectory, marking a fourth consecutive week of gains amid easing trade tensions between China and the U.S., small-cap stocks have been...
12. mai 2025
Neste side